In fact, the strong correlation between FOXO3 and PERK expression at the mRNA level basically supports the notion that FOXO3 regulates PERK expression at the transcriptional level, which is by large independent of the breast cancer subtypes. This evidence concerns the gene FOXO3 and breast cancer.